Am­i­cus launches

Pharmacy Daily - - Front Page -

UK-BASED Am­i­cus Ther­a­peu­tics has to­day con­firmed the de­but of com­mer­cial op­er­a­tions in Aus­tralia, along with the ad­di­tion of its oral pre­ci­sion medicine Galafold (mi­gala­s­tat) on the Life Sav­ing Drugs Pro­gram (LDSP).

Galafold is be­ing listed on the LDSP for the long term treat­ment of Fabry Dis­ease pa­tients aged over 16 with a suit­able ge­netic mu­ta­tion.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.